Rivaroxaban postmarketing risk of liver injury.
Russmann S, Niedrig DF, Budmiger M, Schmidt C, Stieger B, Hürlimann S, Kullak-Ublick GA.
Russmann S, et al.
J Hepatol. 2014 Aug;61(2):293-300. doi: 10.1016/j.jhep.2014.03.026. Epub 2014 Mar 28.
J Hepatol. 2014.
PMID: 24681117
Free article.